|
ZNF384 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34009999763762E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.594700E-04 |
| Normal-vs-Stage2 |
2.554400E-02 |
| Normal-vs-Stage3 |
1.180180E-02 |
| Normal-vs-Stage4 |
3.396200E-02 |
| Stage1-vs-Stage2 |
5.432400E-01 |
| Stage1-vs-Stage3 |
6.320200E-01 |
| Stage1-vs-Stage4 |
6.008400E-01 |
| Stage2-vs-Stage3 |
8.632400E-01 |
| Stage2-vs-Stage4 |
9.517200E-01 |
| Stage3-vs-Stage4 |
8.292200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34910000007638E-07 |
| Normal-vs-AfricanAmerican |
1.241960E-03 |
| Normal-vs-Asian |
5.197800E-01 |
| Caucasian-vs-AfricanAmerican |
9.215200E-01 |
| Caucasian-vs-Asian |
5.475800E-01 |
| AfricanAmerican-vs-Asian |
5.508400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.60780000108596E-08 |
| Normal-vs-Female |
3.212200E-04 |
| Male-vs-Female |
7.758000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.135600E-02 |
| Normal-vs-Extreme_Weight |
1.447690E-02 |
| Normal-vs-Obese |
1.6548899999913E-05 |
| Normal-vs-Extreme_Obese |
9.885800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.094400E-01 |
| Normal_Weight-vs-Obese |
1.737010E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.545600E-01 |
| Extreme_Weight-vs-Obese |
7.522300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.432200E-01 |
| Obese-vs-Extreme_Obese |
4.997500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13240000002113E-06 |
| Normal-vs-Age(41-60Yrs) |
2.76710000468583E-08 |
| Normal-vs-Age(61-80Yrs) |
6.750700E-04 |
| Normal-vs-Age(81-100Yrs) |
5.675600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.295370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.596000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.321700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.126630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.137560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.777600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.37230005137212E-10 |
| Normal-VS-Type2 PRCC |
7.331600E-01 |
| Normal-VS-KIRP CIMP |
9.738000E-02 |
| Normal-VS-Unclassified PRCC |
9.596100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.05559999986316E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.671400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.791600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.187200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.879800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.700000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.661700E-02 |
| Normal-vs-N1 |
6.018500E-03 |
| Normal-vs-N2 |
7.081600E-02 |
| N0-vs-N1 |
1.180600E-01 |
| N0-vs-N2 |
1.167810E-01 |
| N1-vs-N2 |
4.765000E-01 |
|
|
